Karo Pharma AB (publ)

DB:KA6N Stock Report

Market Cap: €16.0b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Karo Pharma Management

Management criteria checks 2/4

Key information

Christoffer Lorenzen

Chief executive officer

SEK 12.6m

Total compensation

CEO salary percentage35.8%
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Christoffer Lorenzen's remuneration changed compared to Karo Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-SEK 190m

Mar 31 2022n/an/a

-SEK 141m

Dec 31 2021SEK 13mSEK 5m

-SEK 17m

Sep 30 2021n/an/a

SEK 63m

Jun 30 2021n/an/a

SEK 2m

Mar 31 2021n/an/a

SEK 49m

Dec 31 2020SEK 12mSEK 5m

SEK 82m

Sep 30 2020n/an/a

SEK 86m

Jun 30 2020n/an/a

SEK 87m

Mar 31 2020n/an/a

SEK 55m

Dec 31 2019SEK 16mSEK 2m

SEK 9m

Compensation vs Market: Christoffer's total compensation ($USD1.20M) is below average for companies of similar size in the German market ($USD4.70M).

Compensation vs Earnings: Christoffer's compensation has increased whilst the company is unprofitable.

CEO

Christoffer Lorenzen (47 yo)

3.3yrs

Tenure

SEK 12,564,000

Compensation

Mr. Christoffer Lorenzen has been the Chief Executive Officer of Karo Pharma AB since July 1, 2019. Mr. Lorenzen was an Executive Vice President of Food Cultures & Enzymes at Chr. Hansen Holding A/S from A...

Leadership Team

NamePositionTenureCompensationOwnership
Christoffer Lorenzen
Chief Executive Officer3.3yrsSEK 12.56mno data
Jon Johnsson
Chief Financial Officer3.1yrsno datano data
Jonathan Kimber
Vice President of Operations3.2yrsno datano data
Sofia Kyhlstedt
Vice President of Scientific Affairsno datano datano data
Lisa Westerdahl
VP of Commercial Pharma Operations & Corporate Communicationsno datano datano data
Anna Hale
Chief Marketing Officer1.8yrsno datano data
Karin Lindberg
Head of People & Organization2.5yrsno datano data
SIMON Nyberg-Hansen
Managing Director of Norwayno datano datano data
Fredrik Thorsen
Head of Digital & E-commerce1.5yrsno datano data
Matt Roberts
Chief Commercial Officer1.2yrsno datano data
Robin List
Chief Executive Officer of Sylpharless than a yearno datano data
Anna Elmblad
Vice President of Digital Marketingno datano datano data

2.2yrs

Average Tenure

47yo

Average Age

Experienced Management: KA6N's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mark Keatley
Independent Director1.6yrsSEK 413.00kno data
Uta Kemmerich-Keil
Independent Director2.5yrsSEK 394.00kno data
Erika Henriksson
Director3.8yrsSEK 394.00kno data
Flemming Ørnskov
Independent Director3.1yrsSEK 394.00kno data
Kristofer Tonström
Independent Director2.5yrsSEK 394.00kno data
Patrick Smallcombe
Independent Chairman1.6yrsSEK 552.00kno data
Claire Hennah
Independent Directorless than a yearno datano data

2.5yrs

Average Tenure

56yo

Average Age

Experienced Board: KA6N's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/27 17:46
End of Day Share Price 2022/11/24 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Karo Pharma AB (publ) is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander LindströmABG Sundal Collier
Camilla OxhamreCarnegie Investment Bank AB
Mats LissKepler Cheuvreux